Terms ending in 2029
Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,902,247 | SUBSTITUTED-ARYL-2-Phenylethyl-1H-IMIDAZOLE Compounds as Subtype Selective Modulators of Alpha 2B And/Or Alpha 2C Adrenergic Receptors In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 7,993,288 | Anatomical Recognition and Dimensional Analysis of Breast Volume to Assist Breast Surgery In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 8,648,853 | Anatomical Recognition, Orientation and Display of an Upper Torso to Assist Breast Surgery In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 9,129,055 | Anatomical Recognition, Orientation and Display of an Upper Torso to Assist Breast Surgery In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US D721,433 | Unit Dose Vials In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US D721,434 | Unit Dose Vial In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 8,722,097 | Polymeric Microparticles Made in an Oil-In Water Emulsion Comprising a Prostamide In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 8,524,494 | Low Oxygen Tension and BFGF Generates a Multipotent Stem Cell from a Fibroblast in Vitro In force · Medium confidence | Allergan Sales, LLC | In force | Medium confidence | |
| US 8,535,913 | Soluble composition for promoting hair growth produced by the hypoxic culture of fibroblast cells In force · Low confidence | Allergan Sales, LLC | In force | Low confidence | |
| US 10,538,736 | Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions In force · Medium confidence | Allergan Sales, LLC | In force | Medium confidence | |
| 74 more term ends in 2029 · Pro | |||||
10 of 84 patents shown. Soonest term end first, then patent number.
Pro members see all 84.
82 of these are in force and held by Allergan, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.